StonvexLoading…
StonvexStonvexStonvexCore line items from DOCN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $901.43M | $780.62M | $198.48M | $192.48M |
Operating Income | $156.99M | $91.01M | $24.61M | $22.33M |
Net Income | $259.26M | $84.49M | $32.95M | $19.14M |
EPS (Diluted) | $2.52 | $0.89 | $0.33 | $0.20 |
Total Assets | $1.84B | $1.64B | Not available | Not available |
Total Liabilities | $1.87B | $1.84B | Not available | Not available |
Cash & Equivalents | $254.47M | $428.45M | Not available | Not available |
Free Cash Flow OCF − CapEx | $180.52M | $104.56M | Not available | Not available |
Shares Outstanding | 91.95M | 92.23M | 102.59M | 93.83M |